Candida biofilms on implanted biomaterials: a clinically significant problem.
暂无分享,去创建一个
Gordon Ramage | J. Lopez-Ribot | José P. Martínez | G. Ramage | José Pedro Martínez | José Luis López-Ribot
[1] M. Dasgupta,et al. Biofilms and Infection in Dialysis Patients , 2002, Seminars in dialysis.
[2] B. Lytle,et al. Surgical and long-term antifungal therapy for fungal prosthetic valve endocarditis. , 1995, The Annals of thoracic surgery.
[3] H. K. Schutte,et al. Microflora on explanted silicone rubber voice prostheses: taxonomy, hydrophobicity and electrophoretic mobility. , 1994, The Journal of applied bacteriology.
[4] B. Wickes,et al. Characteristics of biofilm formation by Candida albicans. , 2001, Revista iberoamericana de micologia.
[5] M. Ghannoum,et al. Mechanism of Fluconazole Resistance in Candida albicans Biofilms: Phase-Specific Role of Efflux Pumps and Membrane Sterols , 2003, Infection and Immunity.
[6] P. Saip,et al. Totally implantable venous-access ports: local problems and extravasation injury. , 2002, The Lancet. Oncology.
[7] J. A. Perry,et al. Urinary candidiasis: A prospective study in hospital patients , 2004, Urological Research.
[8] G. Baillie,et al. Iron-Limited Biofilms of Candida albicans and Their Susceptibility to Amphotericin B , 1998, Antimicrobial Agents and Chemotherapy.
[9] J. Crump,et al. Intravascular Catheter-Associated Infections , 2000, European Journal of Clinical Microbiology and Infectious Diseases.
[10] S. Hawser. Comparisons of the susceptibilities of planktonic and adherent Candida albicans to antifungal agents: a modified XTT tetrazolium assay using synchronised C. albicans cells. , 1996, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.
[11] David S. Jones,et al. Implications of endotracheal tube biofilm for ventilator-associated pneumonia , 1999, Intensive Care Medicine.
[12] A. Gristina,et al. Biomaterial-centered infection: microbial adhesion versus tissue integration. , 1987, Science.
[13] P. François,et al. Role of Plasma and Extracellular Matrix Proteins in the Physiopathology of Foreign Body Infections , 1998, Annals of vascular surgery.
[14] R. Donlan,et al. Biofilms: Microbial Life on Surfaces , 2002, Emerging infectious diseases.
[15] Ghannoum Ma. Susceptibility testing of fungi and correlation with clinical outcome. , 1997 .
[16] N. Khardori,et al. Biofilms in device-related infections , 1995, Journal of Industrial Microbiology.
[17] B. Wickes,et al. Biofilm Formation by Candida dubliniensis , 2001, Journal of Clinical Microbiology.
[18] M. Ghannoum,et al. Antifungal Resistance of Candidal Biofilms Formed on Denture Acrylic in vitro , 2001, Journal of dental research.
[19] K. Lewis,et al. Riddle of Biofilm Resistance , 2001, Antimicrobial Agents and Chemotherapy.
[20] B. Young,et al. Intra amniotic candidiasis. Case report and meta-analysis of 54 cases , 1999, Journal of perinatal medicine.
[21] L. J. Douglas,et al. Medical importance of biofilms in Candida infections. , 2002, Revista iberoamericana de micologia.
[22] Y. Carmeli,et al. Risk factors for nosocomial candiduria due to Candida glabrata and Candida albicans. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[23] B. Wickes,et al. Inhibition of Candida albicans Biofilm Formation by Farnesol, a Quorum-Sensing Molecule , 2002, Applied and Environmental Microbiology.
[24] H. Giamarellou. Nosocomial cardiac infections. , 2002, The Journal of hospital infection.
[25] Betsy Foxman,et al. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. , 2002, The American journal of medicine.
[26] J. Costerton,et al. Bacterial biofilms: a common cause of persistent infections. , 1999, Science.
[27] A. Hanssen,et al. Delayed reimplantation arthroplasty for candidal prosthetic joint infection: a report of 4 cases and review of the literature. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[28] B. Wickes,et al. Biofilms of Candida albicans and their associated resistance to antifungal agents. , 2001, American clinical laboratory.
[29] G. Baillie,et al. Effect of Growth Rate on Resistance ofCandida albicans Biofilms to Antifungal Agents , 1998, Antimicrobial Agents and Chemotherapy.
[30] Y. Hang,et al. Staged reimplantation of total knee arthroplasty after Candida infection. , 2001, The Journal of arthroplasty.
[31] J. Beney,et al. The direct cost and incidence of systemic fungal infections. , 2002, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[32] B. Wickes,et al. Standardized Method for In Vitro Antifungal Susceptibility Testing of Candida albicansBiofilms , 2001, Antimicrobial Agents and Chemotherapy.
[33] B. Wickes,et al. In Vitro Pharmacodynamic Properties of Three Antifungal Agents against Preformed Candida albicans Biofilms Determined by Time-Kill Studies , 2002, Antimicrobial Agents and Chemotherapy.
[34] T. Inglis,et al. Tracheal tube biofilm as a source of bacterial colonization of the lung , 1989, Journal of clinical microbiology.
[35] G. Reid,et al. Microbial Biofilms: Their Development and Significance for Medical Device—Related Infections , 1999, Journal of clinical pharmacology.
[36] T. Inglis,et al. Evidence for dynamic phenomena in residual tracheal tube biofilm. , 1993, British journal of anaesthesia.
[37] R. Koerner. Contribution of endotracheal tubes to the pathogenesis of ventilator-associated pneumonia. , 1997, The Journal of hospital infection.
[38] S. Challacombe,et al. Denture plaque and adherence of Candida albicans to denture-base materials in vivo and in vitro. , 1999, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.
[39] P. Gilbert,et al. Biofilm Susceptibility to Antimicrobials , 1997, Advances in dental research.
[40] D. Sofianou,et al. Fungal peritonitis complicating peritoneal dialysis during an 11-year period: report of 46 cases. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[41] R. D. McCormick,et al. Guidelines for the prevention of intravascular catheter-related infections. , 2002, Infection control and hospital epidemiology.
[42] I. Raad,et al. Intravascular-catheter-related infections , 1998, The Lancet.
[43] I. Raad. Management of intravascular catheter-related infections. , 2000, The Journal of antimicrobial chemotherapy.
[44] Á. Montero,et al. Candida Infection of Cerebrospinal Fluid Shunt Devices: Report of Two Cases and Review of the Literature , 2000, Acta Neurochirurgica.
[45] L. J. Douglas,et al. Resistance of Candida albicans biofilms to antifungal agents in vitro , 1995, Antimicrobial agents and chemotherapy.
[46] J. Pemán,et al. Candidemia at a Tertiary-Care Hospital: Epidemiology, Treatment, Clinical Outcome and Risk Factors for Death , 2002, European Journal of Clinical Microbiology and Infectious Diseases.
[47] J. Smith,et al. In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872) , 1997, Antimicrobial agents and chemotherapy.
[48] J. Costerton,et al. Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms , 2002, Clinical Microbiology Reviews.
[49] Mahmoud A. Ghannoum,et al. Biofilm Formation by the Fungal PathogenCandida albicans: Development, Architecture, and Drug Resistance , 2001, Journal of bacteriology.
[50] M. Ghannoum,et al. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Labora , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[51] J. Graybill,et al. In Vitro Activity of Caspofungin against Candida albicans Biofilms , 2002, Antimicrobial Agents and Chemotherapy.
[52] J. Tsai,et al. Evaluation of infectious complications of the implantable venous access system in a general oncologic population. , 2003, American journal of infection control.
[53] Douglas Lj,et al. Candida biofilms and their susceptibility to antifungal agents. , 1999 .
[54] L. Mermel,et al. Guidelines for the management of intravascular catheter-related infections. , 2001, Infection control and hospital epidemiology.
[55] Gordon Ramage,et al. The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in Candida albicans. , 2002, FEMS microbiology letters.
[56] B. Wickes,et al. Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. , 2002, The Journal of antimicrobial chemotherapy.
[57] J. Sobel,et al. Nosocomial candiduria: a review. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[58] S. Ell,et al. Candida – ‘the cancer of silastic’ , 1996, The Journal of Laryngology & Otology.
[59] B. Belohradsky,et al. Treatment of Candida albicans Endocarditis: Case Report and a Review , 2003, Infection.
[60] G. Baillie,et al. Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. , 2000, The Journal of antimicrobial chemotherapy.
[61] G. Baillie,et al. Production of extracellular matrix by Candida albicans biofilms. , 1998, Journal of medical microbiology.
[62] K. P. Hui,et al. Structural features of tracheal tube biofilm formed during prolonged mechanical ventilation. , 1995, Chest.
[63] B. C. Webb,et al. Candida-associated denture stomatitis. Aetiology and management: a review. Part 2. Oral diseases caused by Candida species. , 1998, Australian dental journal.
[64] R. M. Donlan,et al. Biofilms and device-associated infections. , 2001, Emerging infectious diseases.
[65] W. Chaffin,et al. Cell Wall and Secreted Proteins ofCandida albicans: Identification, Function, and Expression , 1998, Microbiology and Molecular Biology Reviews.
[66] J. Costerton,et al. Bacterial biofilms in nature and disease. , 1987, Annual review of microbiology.
[67] D. Andes,et al. Development and Characterization of an In Vivo Central Venous Catheter Candida albicans Biofilm Model , 2004, Infection and Immunity.
[68] C. Mateus,et al. Adherence of Candida albicans to Silicone Induces Immediate Enhanced Tolerance to Fluconazole , 2004, Antimicrobial Agents and Chemotherapy.
[69] B. Wickes,et al. Denture stomatitis: a role for Candida biofilms. , 2004, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[70] J. Lopez-Ribot,et al. Candida Biofilms: an Update , 2005, Eukaryotic Cell.
[71] M. Ghannoum,et al. Antifungal Susceptibility of Candida Biofilms: Unique Efficacy of Amphotericin B Lipid Formulations and Echinocandins , 2002, Antimicrobial Agents and Chemotherapy.
[72] M. Ghannoum,et al. Comparison of Biofilms Formed by Candidaalbicans and Candidaparapsilosis on Bioprosthetic Surfaces , 2002, Infection and Immunity.
[73] J. Bradley,et al. The treatment of Candida albicans shunt infections , 2000, Child's Nervous System.
[74] D. M. Walker,et al. Denture stomatitis: a review. , 1987, Journal of oral rehabilitation.
[75] R. Donlan. Biofilm formation: a clinically relevant microbiological process. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[76] L. J. Douglas,et al. Biofilm formation by Candida species on the surface of catheter materials in vitro , 1994, Infection and immunity.
[77] C. Beck-Sague,et al. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. , 1993, The Journal of infectious diseases.
[78] L. J. Douglas,et al. Candida biofilms and their role in infection. , 2003, Trends in microbiology.